Evidence map›Paper›PMID 29707805›Full record

ArticleThe Journal of physiology2018

Intestinal absorption of glucose in mice as determined by positron emission tomography.

Monica Sala-Rabanal, Chiara Ghezzi, Bruce A Hirayama, Vladimir Kepe, Jie Liu, Jorge R Barrio, Ernest M Wright

Open access · hybridAbstract read
In one paragraph

Article in The Journal of physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The Metabolic Syndrome, a Human Disease.International journal of molecular sciences · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Canagliflozin Increases Intestinal Adenoma Burden in Female ApcMin/+ Mice.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Article
  17. Article
  18. Bioengineered · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Monica Sala-RabanalDepartment of Physiology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1571, USA.
Chiara GhezziDepartment of Physiology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1571, USA.
Bruce A HirayamaDepartment of Physiology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1571, USA.
Vladimir KepeDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1735, USA.
Jie LiuDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1735, USA.
Jorge R BarrioDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1735, USA.
Ernest M WrightDepartment of Physiology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095-1571, USA.ORCID 0000-0002-1023-4391
University of California, Los Angeles · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
MOLECULAR MECHANISMS OF INTESTINAL TRANSPORTR01DK019567 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WRIGHT, ERNEST M · 1986 to 2013
$4.3M
Role of SGLTs in Glucose Homeostasis and Tissue MetabolismR01DK077133 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WRIGHT, ERNEST M · 2008 to 2011
$1.3M
NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK019567NIDDK NIH HHS R01 DK077133
6 · The paper itself

Abstract

key pointsThe goal was to determine the importance of the sodium-glucose cotransporter SGLT1 and the glucose uniporter GLUT2 in intestinal glucose absorption during oral glucose tolerance tests (OGTTs) in mice. Glucose absorption was determined in mice using positron emission tomography and three non-metabolizable glucose probes: one specific for SGLTs, one specific for GLUTs, and one a substrate for both SGLTs and GLUTs. Absorption was determined in wild-type, Sglt1 ABSTRACT: The current model of intestinal absorption is that SGLT1 is responsible for transport of glucose from the lumen into enterocytes across the brush border membrane, and GLUT2 for the downhill transport from the epithelium into blood across the basolateral membrane. Nevertheless, questions remain about the importance of these transporters in vivo. To address these questions, we have developed a non-invasive imaging method, positron emission tomography (PET), to monitor intestinal absorption of three non-metabolized glucose tracers during standard oral glucose tolerance tests (OGTTs) in mice. One tracer is specific for SGLTs (α-methyl-4-[

Indexed as

Intestinal AbsorptionAnimalsBiological TransportFemaleGlucoseGlucose Tolerance TestGlucose Transporter Type 2Intestine, SmallMaleMiceMice, Inbred C57BLMice, KnockoutPositron-Emission TomographySodium-Glucose Transporter 1GlucoseGlucose Transporter Type 2Slc2a2 protein, mouseSlc5a1 protein, mouseSodium-Glucose Transporter 1absorptionintestinePET

Identifiers

PMID29707805
PMCPMC6023830
OpenAlexW2811429631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.